- Active Pharmaceutical Ingredients
- API Under Development
- Doxofylline IP/BP/USP
- Montelukast IP/BP/USP
- Losartan Potassium
- Losartan Potassium
- 5-Bromo-2-Chloro benzoic Acid
- 5-Iodo 2-Methyl Benzoic Acid
- Itraconazole IP/ USP / EP/ BP
- Fexofenadine Hydrochloride IP/ BP/ USP
- Ticagrelor IP/BP/USP
- Dapagliflozin IP/BP/USP
- EDC HCL (Intermediate of Gliptin Series API)
- Cetirizine Dihyrochloride IP / EP / USP
- View All
- API Intermediates
- 6-Fluoro-3 4-Dihydro-2- Oxiranyl-2H-1-Benzopyran (Stage -NB-6)
- 2-Iodo Benzoic Acid
- 2-Chloro 5 iodo benzoic Acid
- 5-bromo-2-chloro benzoic acid
- 5-bromo-2-chlorophenyl 4-ethoxypheny methanone
- Edc Hcl (Intermediate Of Gliptin Series Api)
- 6-fluro-3,4-dihydro-2-oxiranyl -2h-1-benzopyran (Stage -nb-6b)
- Tamsulosin Base
- Di-para- toluoyl-d-tartaric-acid-monohydrate
- N-Benzyl Nebivolol (Stage -NB-8)
- 6-Fluoro-3 4-Dihydro 2h-1-Benzopyran-Benzoyl 2-Carboxylic Acid (NB-3)
- 4-5 bromo-2-chlorobenzyl phenol
- View All
- Speciality Chemicals
- Di--iodo Methane
- Di-Para Toluoyl D-Tartaric Acid
- Di-benzoyl-D-Tartaric Acid
- Di-Para Toluoyl L-Tartaric Acid
- Di-benzoyl-L-Tartaric Acid
- Chloro-iodo Methane
- 2-Chloro-5-Iodo-Benzoic Acid
- 5-Iodo-2-Methyl Benzoic Acid
- Di-Iodo -Methane
- Chloro-iodo-methane
- Di-iodo Methane
- 5-Bromo 2-Chloro Benzoic Acid
- View All